Longeveron (LGVN) Current Assets (2021 - 2026)
Longeveron's (LGVN) quarterly Current Assets came in at $16.9 million in Q1 2026, up 10.34% year-on-year from $15.3 million in Q1 2025, and up 209.21% quarter-over-quarter from $5.5 million in Q4 2025.
Longeveron (LGVN) Current Assets (2021 - 2026) Analysis & Trends
Longeveron's Current Assets history runs 6 years deep, the most recent figure standing at $16.9 million for Q1 2026.
- On a quarterly basis, Current Assets rose 10.34% year-over-year to $16.9 million in Q1 2026; TTM through Mar 2026 was $16.9 million, a 10.34% increase from a year earlier, with the FY2025 full-year figure at $5.5 million, down 72.22% from the prior year.
- Current Assets climbed to $16.9 million in Q1 2026 per LGVN's latest filing, from $5.5 million in the prior quarter.
- Across five years, Current Assets topped out at $23.8 million in Q3 2024 and bottomed at $3.8 million in Q1 2024.
- The 5-year median for Current Assets is $12.3 million (2024), against an average of $12.6 million.
- Biggest YoY gain for Current Assets was 371.19% in 2024; the steepest drop was 74.73% in 2024.
- Year by year, Current Assets stood at $20.3 million in 2022, then sank by 71.16% to $5.8 million in 2023, then soared by 235.57% to $19.6 million in 2024, then plunged by 72.22% to $5.5 million in 2025, then soared by 209.21% to $16.9 million in 2026.
- Per Business Quant, the three latest LGVN Current Assets figures stand at $16.9 million (Q1 2026), $5.5 million (Q4 2025), and $10.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Longeveron | 3.97 Mn | -11.79 Mn | 264,000.00 | 16.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.86 Mn |
| Dec 31, 2025 | 5.45 Mn |
| Sep 30, 2025 | 10.34 Mn |
| Jun 30, 2025 | 11.27 Mn |
| Mar 31, 2025 | 15.28 Mn |
| Dec 31, 2024 | 19.62 Mn |
| Sep 30, 2024 | 23.77 Mn |
| Jun 30, 2024 | 13.41 Mn |
| Mar 31, 2024 | 3.76 Mn |
| Dec 31, 2023 | 5.85 Mn |
| Sep 30, 2023 | 5.04 Mn |
| Jun 30, 2023 | 10.29 Mn |
| Mar 31, 2023 | 14.87 Mn |
| Dec 31, 2022 | 20.28 Mn |
| Dec 31, 2021 | 35.38 Mn |